These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38267322)

  • 1. [The arguments favoring autologous haematopoietic stem cell transplantation in systemic scleroderma].
    Pugnet G
    Rev Med Interne; 2024 Feb; 45(2):104-108. PubMed ID: 38267322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma.
    Sullivan KM; Goldmuntz EA; Keyes-Elstein L; McSweeney PA; Pinckney A; Welch B; Mayes MD; Nash RA; Crofford LJ; Eggleston B; Castina S; Griffith LM; Goldstein JS; Wallace D; Craciunescu O; Khanna D; Folz RJ; Goldin J; St Clair EW; Seibold JR; Phillips K; Mineishi S; Simms RW; Ballen K; Wener MH; Georges GE; Heimfeld S; Hosing C; Forman S; Kafaja S; Silver RM; Griffing L; Storek J; LeClercq S; Brasington R; Csuka ME; Bredeson C; Keever-Taylor C; Domsic RT; Kahaleh MB; Medsger T; Furst DE;
    N Engl J Med; 2018 Jan; 378(1):35-47. PubMed ID: 29298160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health-related quality of life in systemic sclerosis before and after autologous haematopoietic stem cell transplant-a systematic review.
    Puyade M; Maltez N; Lansiaux P; Pugnet G; Roblot P; Colmegna I; Hudson M; Farge D
    Rheumatology (Oxford); 2020 Apr; 59(4):779-789. PubMed ID: 31504944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes linked to eligibility for stem cell transplantation trials in diffuse cutaneous systemic sclerosis.
    Spierings J; Nihtyanova SI; Derrett-Smith E; Clark KEN; van Laar JM; Ong V; Denton CP
    Rheumatology (Oxford); 2022 May; 61(5):1948-1956. PubMed ID: 34314500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial.
    Burt RK; Shah SJ; Dill K; Grant T; Gheorghiade M; Schroeder J; Craig R; Hirano I; Marshall K; Ruderman E; Jovanovic B; Milanetti F; Jain S; Boyce K; Morgan A; Carr J; Barr W
    Lancet; 2011 Aug; 378(9790):498-506. PubMed ID: 21777972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cardiopulmonary function before and after cyclophosphamide treatment in severe systemic sclerosis: comparison of monthly intravenous bolus and autologous haematopoietic stem cell transplantation].
    Toledano C; Henegar C; Ilie D; Launay D; Tiev K; Marie I; Marjanovic Z; Emmerich J; Cabane J; Ménasché S; Farge D
    Rev Med Interne; 2005 Jun; 26(6):444-52. PubMed ID: 15936473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Autologous peripheral stem cell transplantation in systemic sclerosis: An important step forward, but we must temper our enthusiasm!].
    Mouthon L
    Rev Med Interne; 2024 Feb; 45(2):100-103. PubMed ID: 38238136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD34-selected versus unmanipulated autologous haematopoietic stem cell transplantation in the treatment of severe systemic sclerosis: a post hoc analysis of a phase I/II clinical trial conducted in Japan.
    Ayano M; Tsukamoto H; Mitoma H; Kimoto Y; Akahoshi M; Arinobu Y; Miyamoto T; Horiuchi T; Niiro H; Nagafuji K; Harada M; Akashi K
    Arthritis Res Ther; 2019 Jan; 21(1):30. PubMed ID: 30670057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis.
    Vonk MC; Marjanovic Z; van den Hoogen FH; Zohar S; Schattenberg AV; Fibbe WE; Larghero J; Gluckman E; Preijers FW; van Dijk AP; Bax JJ; Roblot P; van Riel PL; van Laar JM; Farge D
    Ann Rheum Dis; 2008 Jan; 67(1):98-104. PubMed ID: 17526554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomised, open-label trial to assess the optimal treatment strategy in early diffuse cutaneous systemic sclerosis: the UPSIDE study protocol.
    Spierings J; van Rhenen A; Welsing PM; Marijnissen AC; De Langhe E; Del Papa N; Dierickx D; Gheorghe KR; Henes J; Hesselstrand R; Kerre T; Ljungman P; van de Loosdrecht AA; Marijt EW; Mayer M; Schmalzing M; Schroers R; Smith V; Voll RE; Vonk MC; Voskuyl AE; de Vries-Bouwstra JK; Walker UA; Wuttge DM; van Laar JM
    BMJ Open; 2021 Mar; 11(3):e044483. PubMed ID: 33737437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous stem cell transplantation for progressive systemic sclerosis: a prospective non-interventional study from the European Society for Blood and Marrow Transplantation Autoimmune Disease Working Party.
    Henes J; Oliveira MC; Labopin M; Badoglio M; Scherer HU; Del Papa N; Daikeler T; Schmalzing M; Schroers R; Martin T; Pugnet G; Simoes B; Michonneau D; Marijt EWA; Lioure B; Olivier Bay J; Snowden JA; Rovira M; Huynh A; Onida F; Kanz L; Marjanovic Z; Farge D
    Haematologica; 2021 Feb; 106(2):375-383. PubMed ID: 31949011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous bone marrow transplantation in the treatment of refractory systemic sclerosis: early results from a French multicentre phase I-II study.
    Farge D; Marolleau JP; Zohar S; Marjanovic Z; Cabane J; Mounier N; Hachulla E; Philippe P; Sibilia J; Rabian C; Chevret S; Gluckman E;
    Br J Haematol; 2002 Dec; 119(3):726-39. PubMed ID: 12437652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of autologous haematopoietic stem cell transplantation in systemic sclerosis: a systematic review of the literature.
    Eyraud A; Scouppe L; Barnetche T; Forcade E; Lazaro E; Duffau P; Richez C; Seneschal J; Truchetet ME;
    Br J Dermatol; 2018 Mar; 178(3):650-658. PubMed ID: 28906550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autologous HSCT in systemic sclerosis: a step forward.
    Farge D; Gluckman E
    Lancet; 2011 Aug; 378(9790):460-2. PubMed ID: 21777973
    [No Abstract]   [Full Text] [Related]  

  • 15. Hematopoietic stem cell transplantation for systemic sclerosis: history and current status.
    Burt RK; Milanetti F
    Curr Opin Rheumatol; 2011 Nov; 23(6):519-29. PubMed ID: 21857226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of conventionally-treated systemic sclerosis patients eligible for autologous haematopoietic stem cell transplantation.
    Panopoulos ST; Tektonidou MG; Bournia VK; Laskari K; Sfikakis PP
    Clin Exp Rheumatol; 2021; 39 Suppl 131(4):29-33. PubMed ID: 33200737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and Molecular Findings After Autologous Stem Cell Transplantation or Cyclophosphamide for Scleroderma: Handling Missing Longitudinal Data.
    Keyes-Elstein L; Pinckney A; Goldmuntz E; Welch B; Franks JM; Martyanov V; Wood TA; Crofford L; Mayes M; McSweeney P; Nash R; Georges G; Csuka ME; Simms R; Furst D; Khanna D; Clair EWS; Whitfield ML; Sullivan KM
    Arthritis Care Res (Hoboken); 2023 Feb; 75(2):307-316. PubMed ID: 34533286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A successful case of second autologous haematopoietic stem cell transplantation for post-transplant systemic sclerosis relapse.
    Hou Y; Li HJ; Li MT; Xu D; Zhou DB; Zeng XF
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):207. PubMed ID: 26885724
    [No Abstract]   [Full Text] [Related]  

  • 19. Autologous hematopoietic stem cell transplantation for systemic sclerosis.
    Milanetti F; Bucha J; Testori A; Burt RK
    Curr Stem Cell Res Ther; 2011 Mar; 6(1):16-28. PubMed ID: 20955159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic Sclerosis as an Indication for Autologous Hematopoietic Cell Transplantation: Position Statement from the American Society for Blood and Marrow Transplantation.
    Sullivan KM; Majhail NS; Bredeson C; Carpenter PA; Chatterjee S; Crofford LJ; Georges GE; Nash RA; Pasquini MC; Sarantopoulos S; Storek J; Savani B; St Clair EW
    Biol Blood Marrow Transplant; 2018 Oct; 24(10):1961-1964. PubMed ID: 29953945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.